Streetbeat News

Price Targets

FSR

Fisker Inc (NYSE:FSR) CEO Henrik Fisker reported that the company's revised pricing strategy for the high-end trim of its Ocean SUV is effective, with increased consumer interest in the Extreme trim following a price cut. Fisker lowered the price of the Ocean Extreme by $7,500 to $61,499, while raising prices for the Ultra and Sport trims. Despite not qualifying for the IRA tax discount, Fisker sees strong demand in the U.S. and competitive pricing in Europe due to lower logistics costs. The company reported Q3 revenue of $71.8 million and a reduced loss per share of 27 cents. However, Fisker has lowered its 2023 production forecast to 13,000-17,000 vehicles from the previous estimate of 20,000-23,000.

Portfolio Pulse from Anan Ashraf

November 14, 2023 | 8:45 am

LPTX

Raymond James analyst Steven Seedhouse has maintained an Outperform rating on Leap Therapeutics (NASDAQ:LPTX) but reduced the price target from $18.5 to $17.5.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 8:42 am

MNDY

Keybanc analyst Jason Celino has maintained an Overweight rating on Monday.Com (NASDAQ:MNDY) and increased the price target from $180 to $185.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 8:40 am

BTCUSD

Crypto analyst Benjamin Cowen predicts Bitcoin (BTC) could reach $100K by late 2025, based on logarithmic regression bands and historical market cycles. He notes that market cycle highs have been progressively lower in terms of these bands. Cowen's projection is for a peak around $111,000 in two years. Another analyst, DonAlt, expects a surge to $60,000, potentially driven by the approval of a spot-based Bitcoin ETF, which is fueling bullish sentiment.

Portfolio Pulse from Benzinga Neuro

November 14, 2023 | 8:28 am

TNL

Tigress Financial analyst Ivan Feinseth has reaffirmed a Buy rating on Travel+Leisure (NYSE:TNL) and increased the price target from $52 to $54, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 11:36 pm

ANNX

Needham analyst Joseph Stringer has maintained a Buy rating on Annexon (NASDAQ:ANNX) but has reduced the price target from $24 to $16.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 11:32 pm

CELC

Needham analyst Gil Blum has maintained a Buy rating on Celcuity (NASDAQ:CELC) but has reduced the price target from $25 to $23.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 11:29 pm

XERS

HC Wainwright & Co. analyst Oren Livnat has maintained a Buy rating on Xeris Biopharma Holdings (NASDAQ:XERS) but reduced the price target from $6 to $5.5.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 11:27 pm

RVMD

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on Revolution Medicines (NASDAQ:RVMD) but has lowered the price target from $32 to $28.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 11:21 pm

AADI

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on Aadi Bioscience (NASDAQ:AADI) but has reduced the price target from $45 to $36.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 11:15 pm